Profile
Jim Murray is currently Chief Development Operations Officer at TScan Therapeutics, Inc. since 2024.
Formerly, Mr. Murray was Head-Clinical Operations at Rhythm Pharmaceuticals, Inc. from 2017 to 2019, Head-Clinical Operations at Merrimack Pharmaceuticals, Inc. from 2003 to 2017, and Head-Clinical Operations at Repertoire Immune Medicines, Inc. from 2019 to 2021.
Education includes an undergraduate degree from Boston College.
Jim Murray active positions
| Companies | Position | Start |
|---|---|---|
| TSCAN THERAPEUTICS, INC. | Corporate Officer/Principal | 01/03/2024 |
Former positions of Jim Murray
| Companies | Position | End |
|---|---|---|
Repertoire Immune Medicines, Inc.
Repertoire Immune Medicines, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company that engages in immune medicines to prevent, treat and cure cancer | Corporate Officer/Principal | 01/03/2021 |
| RHYTHM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/08/2019 |
| MERRIMACK PHARMACEUTICALS | Corporate Officer/Principal | 01/03/2017 |
Training of Jim Murray
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Rhythm Pharmaceuticals, Inc.
Rhythm Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and supplies peptide therapeutics for rare neuroendocrine diseases | Health Technology |
Merrimack Pharmaceuticals, Inc.
Merrimack Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes drugs for the treatment of immunological & autoimmune diseases and cancer | Health Technology |
Boston College
Boston College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
TScan Therapeutics, Inc.
TScan Therapeutics, Inc. BiotechnologyHealth Technology Develops T-cell therapies for cancer patients | Health Technology |
Repertoire Immune Medicines, Inc.
Repertoire Immune Medicines, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company that engages in immune medicines to prevent, treat and cure cancer | Health Technology |
- Stock Market
- Insiders
- Jim Murray
















